comparemela.com

Forbion Ventures Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Series A supports company launch to advance disease therapies

With a shared focus on developing disease modulating treatments, Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx) have merged to form a new clinical stage company, Calluna Pharma Inc. Click to read more.

Calluna Pharma Launches and Announces EUR 75 Million Series A Financing to Develop Novel Therapies for Inflammatory and Fibrotic Diseases

Calluna Pharma Launches and Announces EUR 75 Million Series A Financing to Develop Novel Therapies for Inflammatory and Fibrotic Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

vimarsana © 2020. All Rights Reserved.